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0900 Registration and refreshments 
0950 Welcome, opening remarks and housekeeping announcement 
 
 
 First session - Chairman: John Skidmore, University of Cambridge 
1000 Trials and tribulations of inhibiting kinases 
 Nadia Ahmad, Vertex Pharmaceuticals 
1030 A protein functionalization platform based on selective reactions at methionine 
 Jennifer Nelson, University of Cambridge 
1100 In vitro myeloid differentiation using a new generation of potent human dihydroorotate 
dehydrogenase inhibitors 
 Stefano Sainas, University of Torino, Italy 
1130 Student flash presentations (prior to lunchtime poster competition) 
 21 presentations each of two minutes  
1215 Lunch and poster session 
 
 
 Second session - Chairman:   Douglas Williamson, Vernalis Research 
1330 The development of Microtubule Affinity Regulating Kinase (MARK) inhibitors 
 Martin Ambler, LifeArc 
1400 Hi-JAK-ing the Ubiquitin system:  the design and physicochemical optimisation of isoform-
specific JAK PROTACs 
 Rishi Shah, University of Strathclyde 
1430 Thorough design and biophysical characterisation yields a highly sensitive reporter molecule 
for detecting protein binding by 19F NMR 
 Vieira de Castro, University of Dundee 
1500 PhABits – PhotoAffinity Bits to study protein-ligand binding 
 Emma Grant, University of Strathclyde 
1530 Refreshments 
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 Third session - Chairman:  Dave Alker, Chemistry Recruitment Consultant 
1600 Next generation drug discovery: TIME, an integrated micro-fluidics based chemistry 
platform 
 Alexander Alanine, Nanna Therapeutics 
1630 Synthesis, computational and biological evaluation of novel benzimidazole compounds for 
the treatment of Cryptococcus neoformans 
 Gina Washbourn, University of Liverpool 
1700 Piezo1 modulators:  small molecules and force 
Kevin Cuthbertson, University of Leeds 
1730 Design and synthesis of dual ALK-BRD4 inhibitors 
 Ellen Watts, Institute of Cancer Research 
1800 Closing remarks 
 Dave Alker, Chemistry Recruitment Consultant 
1810 Wine mixer 
1830 Presentation of prizes 
2000 Close 
Poster Listing 
 
 
Notice to flash slide presenters:  If you are presenting your Flash poster slide today, please sit 
close to the edges of the theatre.  We will run in the order which is listed here below. If you are 
the first speaker, please introduce yourself to the chairman of the session. The next speaker 
should approach the stage whilst the presentation is ongoing.  Note: the slide will change 
automatically to the next slide on a two-minute timer.  The chairman of the session will move the 
slide forward if you finish early. 
 
P01 Anti-adhesives for the treatment of recurrent urinary tract infection by uropathogenic E. coli 
(UPEC):  synthesis of octyl-C-glycoside derivatives 
 Shayma Ahmad, Bangor University 
 
P02 Studies of hydroxycoumarin biosynthesis using istopically labelled cinnamic acids 
 Pamela Amegbletor, University of Bath 
 
P03 All systems are flow:  a continuous flow approach to the synthesis of anti-malarials 
 Blake Baker, University of Strathclyde 
 
P04 Hypoxia-activated epigenetic prodrugs 
 Ewen Calder, University of Oxford 
 
P05 Bioorthogonal decaging for targeted-activation of anti-inflammatory drugs 
 Sarah Davies, University of Cambridge 
 
P06 3,3-diaryloxetanes:  new opportunities for drug discovery  
 Maryne Dubois, Imperial College London 
 
P07 A novel fragment based approach to the design of FXIa inhibitors for the management of 
thrombosis 
 Holly Foster, University of Leeds 
 
P08 From high throughput screen to biological evaluation of endoplasmic reticulum 
aminopeptidase inhibitors for cancer immunotherapy 
 Floriane Gibault, The Institute of Cancer Research 
 
P09 The design, synthesis and evaluation of novel ubiquitin ligase inhibitors 
 Gregory Hughes, University of East Anglia 
 
P10 Chemical tools to probe the role of bromodomains in the parasite Trypanosoma cruzi 
 Corentine Laurin, University of Oxford 
 
P11 Development and characterisation of cell-active tool compounds to evaluate tyrosine 
phosphatase biology 
 Jack Lownes, University of Manchester 
 
P12 Rational design of covalent inhibitors for a bacterial glycosyltransferase 
 Camille Metier, King’s College London 
 
P13 Design of short cationic peptides with potential antimicrobial activity 
 Ilaria Passarini, University of Hertfordshire 
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P14 Targeting cyclophilin D for the treatment of acute pancreatitis  
 Michael Rogers, University of Liverpool 
 
P15 Bioorthogonal chemistry approaches to the cellular imaging of PI3Kδ inhibitors 
 Maxime Rouah, University of Strathclyde 
 
P16 Chemical tools to probe the function of TRIM33 
 Amy Scorah, University of Oxford 
 
P17 Mimicking inositol phosphates with carbohydrate-based ligands 
 Megan Shipton, University of Oxford 
 
P18 Elucidation of insect olfaction in the pea aphid, acyrthosiphon pisum 
 Cassie Sims, Rothamsted Research 
 
P19 Enhanced binding affinity of backbone-modified Locked Nucleic Acid (LNA) oligonucleotides 
for therapeutic targets 
 Cameron Thorpe, University of Oxford 
 
P20 Development of novel tetraoxane containing endoperoxide antimalarials 
 Christopher Woodley, University of Liverpool 
 
P21 Gallic acid and other dietary phenolics from black and greencurrants inhibit PTP1B in vitro 
 Sisir Kumar Barisk, University of Aberdeen 
 
 
 
